Telstra Group Ltd
TLS
Westpac Banking Corp
WBC
CommBank
CBA
4
ANZ Group Holdings Ltd
ANZ
5
National Australia Bank Ltd
NAB
AU Stock MarketDetailed Quotes
PER Percheron Therapeutics Ltd
- 0.011
- -0.002-15.38%
20min DelayMarket Closed Feb 28 16:00 AET
11.96MMarket Cap-0.79P/E (Static)
0.013High0.011Low5.57MVolume0.013Open0.013Pre Close72.03KTurnover0.14052wk High0.75%Turnover Ratio1.09BShares0.00552wk Low-0.014EPS TTM8.18MFloat Cap0.140Historical HighLossP/E (Static)744.05MShs Float0.005Historical Low-0.014EPS LYR15.39%Amplitude--Dividend TTM0.79P/B1Lot Size--Div YieldTTM
About Percheron Therapeutics Ltd Company
Percheron Therapeutics Ltd is a biotechnology company, developing and commercializing antisense pharmaceuticals for large unmet markets in rare diseases. The company operates into two operating segment: ATL1102 and ATL1103. Key revenue is generated from ATL1102.
Company Profile
SymbolPER
Company NamePercheron Therapeutics Ltd
Founded2000
MarketASX
Employees3
Fiscal Year Ends06-30
Address14 Wallace Avenue LEVEL 1
CityToorak
CountryAustralia
Zip Code3142
Phone+61 398278999
Websitehttps://www.percherontx.com
Share RegistryBOARDROOM PTY LIMITED
LEVEL 8, 210 GEORGE STREET, SYDNEY, NSW, AUSTRALIA, 2000
(02) 9290 9600
Company Executives
- Name
- Position
- Salary
- James Garner
- Chief Executive Officer,Managing Director
- --
- Charmaine Gittleson
- Executive Chairman,Executive Director
- --
- Ben Gil Price
- Non-Executive Director
- --